NCT00415428
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
158 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
NCT00442325
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
- Locations
-
- Pfizer Investigational Site Ioannina, Greece
- Pfizer Investigational Site Kallithea, Athens, Greece
- Pfizer Investigational Site Pireaus, Greece
- Pfizer Investigational Site Thessaloniki, Greece
NCT00442845
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
- Locations
-
- Pfizer Investigational Site Mississauga, Ontario, Cameroon
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
- Pfizer Investigational Site Medicine Hat, Alberta, Canada
NCT04097483
- Conditions
- Behavior, Behavioral Symptoms, Depression, +8 more
- Locations
-
Not specified
NCT03288740
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Beijing, China
NCT03646721
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Clinical Site Chula Vista, California, United States
- Clinical Pharmacology of Miami Miami, Florida, United States
- High Point Clinical Trials Center High Point, North Carolina, United States
- Rainier Clinical Research Center Renton, Washington, United States
NCT03064321
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyssomnias, +10 more
- Locations
-
- University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States
NCT03371355
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +13 more
- Locations
-
- Clinical Sites Chandler, Arizona, United States
- Clinical Site Fountain Hills, Arizona, United States
- Clinical Site Glendale, Arizona, United States
- Clinical Site Mesa, Arizona, United States
NCT00645268
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Beverly Hills, California, United States
- Pfizer Investigational Site Duarte, California, United States
NCT04244110
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- CAP Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain